|
1
|
Khan R and Ly HQ: Transradial percutaneous
coronary interventions in acute coronary syndrome. Am J Cardiol.
114:160–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amarenco P, Abboud H, Labreuche J, Arauz
A, Bryer A, Lavados PM, Massaro A, Munoz Collazos M, Steg PG,
Yamout BI and Vicaut E: OPTIC Registry Investigators: Impact of
living and socioeconomic characteristics on cardiovascular risk in
ischemic stroke patients. Int J Stroke. 9:1065–1072. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rivera-Fernández R, Arias-Verdú MD,
García-Paredes T, Delgado-Rodríguez M, Arboleda-Sánchez JA,
Aguilar-Alonso E, Quesada-García G and Vera-Almazán A: Prolonged QT
interval in ST-elevation myocardial infarction and mortality: New
prognostic scale with QT, Killip and age. J Cardiovasc Med
(Hagerstown). 17:11–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smith AJ, Lewis FC, Aquila I, Waring CD,
Nocera A, Agosti V, NadalGinard B, Torella D and Ellison GM:
Isolation and characterization of resident endogenous c-Kit+
cardiac stem cells from the adult mouse and rat heart. Nat Protoc.
9:1662–1681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DiStefano R, Felice F, Pini S, Mazzotta G,
Bovenzi FM, Bertoli D, Abelli M, Borelli L, Cardini A, Lari L, et
al: Impact of depression on circulating endothelial progenitor
cells in patients with acute coronary syndromes: A pilot study. J
Cardiovasc Med (Hagerstown). 15:353–359. 2014.PubMed/NCBI
|
|
6
|
Wöhrle J, von Scheidt F, Schauwecker P,
Wiesneth M, Markovic S, Schrezenmeier H, Hombach V, Rottbauer W and
Bernhardt P: Impact of cell number and microvascular obstruction in
patients with bone-marrow derived cell therapy: Final results from
the randomized, double-blind, placebo controlled intracoronary Stem
Cell therapy in patients with Acute Myocardial Infarction (SCAMI)
trial. Clin Res Cardiol. 102:765–770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo H, Li Q, Pramanik J, Luo J and Guo Z:
Nanog expression in heart tissues induced by acute myocardial
infarction. Histol Histopathol. 29:1287–1293. 2014.PubMed/NCBI
|
|
8
|
Carvalho JL, Braga VB, Melo MB, Campos AC,
Oliveira MS, Gomes DA, Ferreira AJ, Santos RA and Goes AM: Priming
mesenchymal stem cells boosts stem cell therapy to treat myocardial
infarction. J Cell Mol Med. 17:617–625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rahbarghazi R, Nassiri SM, Ahmadi SH,
Mohammadi E, Rabbani S, Araghi A and Hosseinkhani H: Dynamic
induction of pro-angiogenic milieu after transplantation of
marrow-derived mesenchymal stem cells in experimental myocardial
infarction. Int J Cardiol. 173:453–466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malick M, Gilbert K, Barry M, Godbout R
and Rousseau G: Desvenlafaxine reduces apoptosis in amygdala after
myocardial infarction. Brain Res Bull. 109:158–163. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naaijkens BA, van Dijk A, Meinster E,
Kramer K, Kamp O, Krijnen PA, Niessen HW and Juffermans LJ: Wistar
rats from different suppliers have a different response in an acute
myocardial infarction model. Res Vet Sci. 96:377–379. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chong JJ, Chandrakanthan V, Xaymardan M,
Asli NS, Li J, Ahmed I, Heffernan C, Menon MK, Scarlett CJ,
Rashidianfar A, et al: Adult cardiac-resident MSC-like stem cells
with aproepicardial origin. Cell Stem Cell. 9:527–540. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reuther S, Reiter M, Raabe A and Dikomey
E: Effect of irradiation on the expression of DNA repair genes
studied in human fibroblasts by real-time qPCR using three methods
of reference gene validation. Radiat Environ Biophys. 52:463–469.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Anders B, Alonso A, Artemis D, Schäfer A,
Ebert A, Kablau M, Fluechter S, Findeisen P, Hennerici MG and Fatar
M: What does elevated high-sensitive troponin I in stroke patients
mean: Concomitant acute myocardial infarction or a marker for
high-risk patients? Cerebrovasc Dis. 36:211–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Regnault V, Lagrange J, Pizard A, Safar
ME, Fay R, Pitt B, Challande P, Rossignol P, Zannad F and Lacolley
P: Opposite predictive value of pulse pressure and aortic pulse
wave velocity on heart failure with reduced left ventricular
ejection fraction: Insights from an Eplerenone Post-Acute
Myocardial Infarction Heart Failure Efficacy and Survival Study
(EPHESUS) substudy. Hypertension. 63:105–111. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Crafts TD, Jensen AR, BlocherSmith EC and
Markel TA: Vascular endothelial growth factor: Therapeutic
possibilities and challenges for the treatment of ischemia.
Cytokine. 71:385–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Przybyt E, Krenning G, Brinker MG and
Harmsen MC: Adipose stromal cells primed with hypoxia and
inflammation enhance cardiomyocyte proliferation rate in vitro
through STAT3 and Erk1/2. J Transl Med. 11:392013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishikawa K, Fish K, Aguero J, YanizGalende
E, Jeong D, Kho C, Tilemann L, Fish L, Liang L and Eltoukhy AA:
Stem cell factor gene transfer improves cardiac function after
myocardial infarction in swine. Circ Heart Fail. 8:167–174. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malliaras K, Makkar RR, Smith RR, Cheng K,
Wu E, Bonow RO, Marbán L, Mendizabal A, Cingolani E, Johnston PV,
et al: Intracoronary cardiosphere-derived cells after myocardial
infarction: Evidence of therapeutic regeneration in the final
1-year results of the CADUCEUS trial (Cardiosphere-Derived
autologous stem Cells to reverse ventricular dysfunction). J Am
Coll Cardiol. 63:110–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Galiger C, Kostin S, Golec A, Ahlbrecht K,
Becker S, Gherghiceanu M, Popescu LM, Morty RE, Seeger W and
Voswinckel R: Phenotypical and ultrastructural features of
Oct4-positive cells in the adult mouse lung. J Cell Mol Med.
18:1321–1333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mendjan S, Mascetti VL, Ortmann D, Ortiz
M, Karjosukarso DW, Ng Y, Moreau T and Pedersen RA: NANOG and CDX2
pattern distinct subtypes of human mesoderm during exit from
pluripotency. Cell Stem Cell. 15:310–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Senyo SE, Steinhauser ML, Pizzimenti CL,
Yang VK, Cai L, Wang M, Wu TD, GuerquinKern JL, Lechene CP and Lee
RT: Mammalian heart renewal by pre-existing cardiomyocytes. Nature.
493:433–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mitsui K, Masamune T, Okuyama K, Oguchi T,
Furuya A, Iwashita H, Ishiyama T and Matsukawa T: A case of severe
hypotension caused by external cardiac compression by tumor and
doctor's hand in a patient with mediastinal tumor. Masui.
62:204–208. 2013.PubMed/NCBI
|
|
25
|
Lahm H, Doppler S, Dreßen M, Werner A,
Adamczyk K, Schrambke D, Brade T, Laugwitz KL, Deutsch MA,
Schiemann M, et al: Live fluorescent RNA-based detection of
pluripotency gene expression in embryonic and induced pluripotent
stem cells of different species. Stem Cells. 33:392–402. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kajstura J, Rota M, Cappetta D, Ogórek B,
Arranto C, Bai Y, Ferreira-Martins J, Signore S, Sanada F, Matsuda
A, et al: Cardiomyogenesis in the aging and failing human heart.
Circulation. 126:1869–1881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cieslik KA, Trial J, Crawford JR, Taffet
GE and Entman ML: Adverse fibrosis in the aging heart depends on
signaling between myeloid and mesenchymal cellRole of inflammatory
fibroblasts. J Mol Cell Cardiol. 70:56–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duran JM, Makarewich CA, Sharp TE,
Starosta T, Zhu F, Hoffman NE, Chiba Y, Madesh M, Berretta RM, Kubo
H, et al: Bone-derived stem cells repair the heart after myocardial
infarction through transdifferentiation and paracrine signaling
mechanisms. Circ Res. 113:539–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wehman B, Sharma S, Mishra R, Guo Y,
Colletti EJ, Kon ZN, Datla SR, Siddiqui OT, Balachandran K and
Kaushal S: Pediatric End-Stage Failing Hearts Demonstrate Increased
Cardiac Stem Cells. Ann Thorac Surg. 100:615–622. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hariharan N, Quijada P, Mohsin S, Joyo A,
Samse K, Monsanto M, De La Torre A, Avitabile D, Ormachea L,
McGregor MJ, et al: Nucleostemin rejuvenates cardiac progenitor
cells and antagonizes myocardial aging. J Am Coll Cardiol.
65:133–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chugh AR, Beache GM, Loughran JH, Mewton
N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima
JA, et al: Administration of cardiac stem cells in patients with
ischemic cardiomyopathy: The SCIPIO trial: Surgical aspects and
interim analysis of myocardial function and viability by magnetic
resonance. Circulation. 126(11): Suppl 1. S54–S64. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ellison GM, Galuppo V, Vicinanza C, Aquila
I, Waring CD, Leone A, Indolfi C and Torella D: Cardiac stem and
progenitor cell identification: Different markers for the same
cell? Front Biosci (Schol Ed). 2:641–652. 2010.PubMed/NCBI
|
|
33
|
Xue C, Zhang J, Lv Z, Liu H, Huang C, Yang
J and Wang T: Angiotensin II promotes differentiation of mouse
c-kit-positive cardiac stem cells into pacemaker-like cells. Mol
Med Rep. 11:3249–3258. 2015.PubMed/NCBI
|
|
34
|
Fortini C, Cesselli D, Beltrami AP,
Bergamin N, Caragnano A, Moretti L, Cecaro F, Aquila G, Rizzo P,
Riberti C, et al: Alteration of Notch signaling and functionality
of adipose tissue derived mesenchymal stem cells in heart failure.
Int J Cardiol. 174:119–126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Igura K, Okada M, Kim HW and Ashraf M:
Identification of small juvenile stem cells in aged bone marrow and
their therapeutic potential for repair of the ischemic heart. Am J
Physiol Heart Circ Physiol. 305:H1354–H1362. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jasmin, Jelicks LA, Tanowitz HB, Peters
VM, Mendez-Otero R, Campos de Carvalho AC and Spray DC: Molecular
imaging, biodistribution and efficacy of mesenchymal bone marrow
cell therapy in a mouse model of Chagas disease. Microbes Infect.
16:923–935. 2014. View Article : Google Scholar : PubMed/NCBI
|
